Market Scenario

Market Research Future (MRFR) speculates that the Global Facial Injectors Market is expected to grow at a high CAGR of 11.40% during the forecasted period from 2022-2030 and to reach the market value of USD 14571.47 million by the end of the forecasted period 2022-2030.

Facial Injectors Market Information By Type (Dermal Fillers/Injectable Implants, Hyaluronic Acid, Synthetic Fillers, Collagen Fillers, Anti-Aging/Anti-Wrinkle Injections, Botulinum Toxin A, Poly-L-Lactic Acid (PLLA) Microparticles), By Application (Facial Line Correction Treatment, Face-Lift, Lip Treatments), By End-User (Dermatology Clinics & Cosmetic Centres, Hospitals), By Region (Americas, Europe, Asia Pacific and The Middle East & Africa) – Global Forecasts till 2030

Facial Injectors are used to inject the facial filler products like calcium hydroxyl apatite, collagen, and hyaluronic acid in order to rejuvenate the facial skin by reducing the wrinkles, raising the scar depressions, enhancing the lips, and substituting the soft-tissue volume loss. The surging demand for facial aesthetic treatments is likely to favour the market growth.

Request Free Sample Copy at: 

https://www.marketresearchfuture.com/sample_request/6898

Market Potential and Pitfalls

The Facial Injectors Market is experiencing an upward growth trajectory globally mainly due to the surging demand for facial aesthetic treatments coupled with the rising popularity of cosmetic surgery especially in the developing economies. The continuous improvement in surgical procedures due to advancing technology along with the adverse effects of the ever increasing population is highly influencing the market growth.  With the booming entertainment sector and the rising popularity of celebrity culture across the globe, the lifestyle of the urban population has been affected which has raised the bar higher for beauty standards. The growing R&D activities for the development of advanced aesthetic injectors like soft tissue filler and surging demand for anti-aging and other treatments are some of the major factors contributing to the market worldwide. Moreover, the increased awareness coupled with the acceptance of combination therapies are likely to propel the market’s growth in the long run.

The rising number of male population opting for aesthetic procedures is likely to favor the market growth across the globe. Patient population is opting for procedures like acne treatment, lip augmentation, scars treatment, face lift, and aesthetic procedures. These are considered some of the most common type of procedures which require facial injectable. According to a study by AASPS, around 9.0% of the total procedures which were performed in 2015 were by the male population. This is estimated to impact the market positively globally.

On the contrary, the side effects of facial injectors, complications associated during the surgeries, and high availability of black market for facial injectors are some of the top barriers likely to vitiate the market growth during the appraisal period.

Global Facial Injectors Market: Segmental Analysis

The Global Facial Injectors Market has been segmented on the basis of type, application, end-user.

By mode of type, the global facial injectors market has been segmented into dermal fillers/ injectable implants/ and anti-aging/ anti-wrinkle injections. Among these, the dermal fillers/ injectable implants segment is likely to command the largest market share of USD 7934.80.

By mode of application, the global facial injectors market has been segmented into face-lift, facial line correction treatment, lip treatment, and others. Among these, the face-lift segment is likely to expand at the highest growth rate during the forecast period. The facial line correction treatment segment on the other hand is likely to generate the maximum revenue with a CAGR of 10.43% during the forecast period.

Regional Insights

Geographically, the facial injectors market span across regions namely, Europe, America, Asia Pacific, and the Middle East & Africa.

Considering the global scenario, the American region is expected to spearhead the facial injectors market globally. The market is anticipated to surpass a valuation of 6339.94 owing to the surging popularity of facial aesthetic treatment, high availability of premium-quality treatment, rising disposable income, and introduction of advanced cosmetic technology. 

The Asia Pacific region is predicted to record the strongest growth rate with a CAGR of 12.02%. The growth can be ascribed to the booming entertainment industry which is highly influencing the population especially in the emerging economies. The rising prevalence of cosmetic surgeries and the increased disposable income are further leading to a significant expansion of the market in this region.

Industry Updates

March 07, 2019: Allergan has recently launched Beauty Decoded Live which is the first in a series of global events specifically designed to educate the consumers on facial fillers and the significance of having a proper consultation with a trained practitioner before the treatment

Browse Detailed TOC with COVID-19 Impact Analysis at: 

https://www.marketresearchfuture.com/reports/facial-injectors-market-6898

Competitive Dashboard

The prominent players operating in the global facial injectors market comprises Ipsen Pharma, SciVision Biotech Inc, Sanofi, Merck KGaA, Sinclair Pharma, Revance Therapeutics Inc., Suneva Medical Inc., Galderma S.A., Valeant Pharmaceuticals, Merz Pharma, Integra LifeSciences Corporation, and Allergan.

 

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 628 258 0071

Email: [email protected]